Details for Patent: 10,806,792

« Back to Dashboard

Which drugs does patent 10,806,792 protect, and when does it expire?

Patent 10,806,792 protects TOLSURA and is included in one NDA.

This patent has eighteen patent family members in ten countries.

Summary for Patent: 10,806,792

Title:	Itraconazole compositions and dosage forms, and methods of using the same
Abstract:	The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.
Inventor(s):	Stuart James MUDGE, David Hayes, Stefan Lukas
Assignee:	Mayne Pharma International Pty Ltd
Application Number:	US16/671,606
Patent Claim Types: see list of patent claims	Composition;

Drugs Protected by US Patent 10,806,792

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mayne Pharma	TOLSURA	itraconazole	CAPSULE;ORAL	208901-001	Dec 11, 2018		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 10,806,792

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Australia	2012902624	Jun 21, 2012

International Family Members for US Patent 10,806,792

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013278001
Australia	2018201298
Australia	2020217438
Brazil	112014031706
Canada	2876909
China	104507480
China	109674795